August 2, 2007 — Siemens Medical Solutions Diagnostics announced the availability of the ADVIA 1800 chemistry system ...
August 1, 2007 - Positron Corp. announced that a recent study by The State University of New York at Buffalo reveals that Positron Emission Tomography (PET) scanning when used as the first tool to diagnose heart-vessel blockages, is more accurate, less invasive and cost effective than SPECT imaging.
August 1, 2007 - AGA Medical Corp. (AGA), owner of a European patent (EP 0 808 138) for intravascular occlusion devices ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 1, 2007 - SonoSite Inc., a developer of portable ultrasound, announced it has acquired LumenVu Inc., a company ...
August 1, 2007 - BioControl Medical announced that cardiologists at University Hospital Mannheim in Germany and at Ospedali Riuniti di Bergamo in Italy have successfully implanted the CardioFit device in the first patients to be enrolled at those sites in BioControl’s international, multi-center clinical study of the CardioFit system, marking an important step for the treatment of advanced conge
July 31, 2007 - Implantable defibrillators can reduce the risk of sudden death in high-risk patients with hypertrophic cardiomyopathy, according to a new study conducted at the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute Foundation and published in the July 25 issue of the Journal of the American Medical Association.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 31, 2007 — eCardio Diagnostics announced it is expanding its facilities with a new state-of-the-art diagnostic ...
July 31, 2007 - GlaxoSmithKline announced the recommendation of an FDA advisory committee to support Avandia’s (rosiglitazone maleate), an oral anti-diabetic medicine, continued availability to patients in the U.S., information which the FDA will consider its final decision-making process.
July 30, 2007 – The FDA gave Cook Medical, a developer of IVC filters, clearance for a permanent indication for its newest vena cava filter, Celect, which is designed to offer physicians a tool for minimizing the risk of blood clots and pulmonary embolism in their patients.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
July 30, 2007 - Outcome Sciences Inc., a medical software developer, announced that it has added a Continuity of Care Records (CCR) functionality to the its Get With The Guidelines (GWTG) Patient Management Tool (PMT), a data collection and reporting platform for patients with coronary artery disease (CAD), heart failure and stroke, as part of a joint effort with the American Heart Association to
July 27, 2007 - Medicomp Inc., a wholly owned subsidiary of United Therapeutics Corporation, recently introduced ...
July 27, 2007 - Vascular disease frequently shows no symptoms until it is at such an advanced stage that it is difficult ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
July 27, 2007 - Medicomp Inc., a wholly owned subsidiary of United Therapeutics Corporation, recently introduced ...
July 27, 2007 – Cardiac Science Corp., a cardiac monitoring and defibrillation products company, received Frost & ...
July 26, 2007 - St. Jude Medical Inc. announced that the FDA has granted clearance for the 7F Proxis Embolic Protection ...